Henry Zubaida joined Gilde Healthcare in 2018 and focuses on the Healthtech sector. He has been involved in several investments including Big Health, Withings and Volta Medical. He is a board observer at FIRE1, Withings and Volta.
Prior to joining Gilde, Henry worked in business development for Biolinq, a US based start-up developing a novel generation of Continuous Glucose Monitoring. Before, Henry worked at Merck KGaA: at the Innovation Center in Germany (on blockchains applications) and at the corporate venture arm, M Ventures, in the Netherlands (deal sourcing and evaluation). Prior to this, he was a management consultant in London for several years.
Henry is a British citizen with an academic background in Chemistry and a Master’s degree in Bioscience Enterprise from the University of Cambridge. While at Cambridge Henry received the Cambridge University – Young Entrepreneur of the Year Award.